These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20701411)

  • 1. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy.
    Lapi F; Tuccori M; Motola D; Pugi A; Vietri M; Montanaro N; Vaccheri A; Leoni O; Cocci A; Leone R; Conforti A; Moretti U; Sessa E; Mazzaglia G; Mugelli A; Mazzei T; Vannacci A
    Drug Saf; 2010 Sep; 33(9):789-99. PubMed ID: 20701411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.
    Leone R; Venegoni M; Motola D; Moretti U; Piazzetta V; Cocci A; Resi D; Mozzo F; Velo G; Burzilleri L; Montanaro N; Conforti A
    Drug Saf; 2003; 26(2):109-20. PubMed ID: 12534327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
    Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
    Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
    Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
    Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.
    Leone R; Conforti A; Venegoni M; Motola D; Moretti U; Meneghelli I; Cocci A; Sangiorgi Cellini G; Scotto S; Montanaro N; Velo G
    Drug Saf; 2005; 28(6):547-56. PubMed ID: 15924506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use and safety profile of antiepileptic drugs in Italy.
    Iorio ML; Moretti U; Colcera S; Magro L; Meneghelli I; Motola D; Rivolta AL; Salvo F; Velo GP
    Eur J Clin Pharmacol; 2007 Apr; 63(4):409-15. PubMed ID: 17347806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug's safety profile.
    Motola D; Melis M; Lo Bianco S; Buccellato E; Biagi C; Vaccheri A
    Expert Opin Drug Saf; 2014 Jul; 13(7):867-73. PubMed ID: 24809453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions.
    Bonaldo G; Andriani LA; D'Annibali O; Motola D; Vaccheri A
    Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1457-1463. PubMed ID: 31423694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
    Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
    Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study.
    Leone R; Moretti U; D'Incau P; Conforti A; Magro L; Lora R; Velo G
    Drug Saf; 2013 Apr; 36(4):267-76. PubMed ID: 23475583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
    Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
    Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare costs and mortality associated with serious fluoroquinolone-related adverse reactions.
    Kuula LSM; Backman JT; Blom ML
    Pharmacol Res Perspect; 2022 Apr; 10(2):e00931. PubMed ID: 35170862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
    Pugi A; Bonaiuti R; Maggini V; Moschini M; Tuccori M; Leone R; Rossi M; Motola D; Piccinni C; Ferrazin F; Sottosanti L; Mugelli A; Vannacci A; Lapi F
    Am J Health Syst Pharm; 2013 Jun; 70(12):1039-46. PubMed ID: 23719881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from 2004 to 2016.
    Oreagba IA; Oshikoya KA; Ogar C; Adefurin AO; Ibrahim A; Awodele O; Oni Y
    Pharmacol Res Perspect; 2017 Apr; 5(2):e00297. PubMed ID: 28357123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
    Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
    Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
    Auffret M; Labreuche J; Duhamel A; Deheul S; Cottencin O; Bordet R; Gautier S; Rolland B
    Drug Saf; 2017 Mar; 40(3):257-262. PubMed ID: 27988884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study.
    Scavone C; Sessa M; Clementi E; Corrao G; Leone R; Mugelli A; Rossi F; Spina E; Capuano A
    BioDrugs; 2018 Dec; 32(6):607-617. PubMed ID: 30341487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study.
    Gatti M; Raschi E; De Ponti F
    BMC Pharmacol Toxicol; 2019 Nov; 20(1):65. PubMed ID: 31718688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions.
    Naldi L; Conforti A; Venegoni M; Troncon MG; Caputi A; Ghiotto E; Cocci A; Moretti U; Velo G; Leone R
    Br J Clin Pharmacol; 1999 Dec; 48(6):839-46. PubMed ID: 10594488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.